Customized breast cancer risk assessment in an ambulatory clinic: a portal for identifying women at risk-Reference-Cited by-同舟云学术

Customized breast cancer risk assessment in an ambulatory clinic: a portal for identifying women at risk

Published:2019-01-21 Issue:1 Volume:175 Page:229-237
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Weiss Anna,Grossmith Samantha,Cutts Danielle,Mikami Sage A.,Suskin Johanna A.,Graichen Mary Knust,Rojas Negui Arilis,Pace Lydia E.,Joyce Eileen,Rhei Esther,Scheib Rochelle,Bychkovsky Brittany,Garber Judy E.,Morganstern Daniel,King Tari A.^ORCID

Funder

Susan G. Komen

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/article/10.1007/s10549-018-05116-5/fulltext.html

Reference37 articles.

1. Sprague BL, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Hampton JM, Newcomb PA (2008) Proportion of invasive breast cancer attributable to risk factors modifiable after menopause. Am J Epidemiol 168(4):404–411. https://doi.org/10.1093/aje/kwn143

2. Tamimi RM, Spiegelman D, Smith-Warner SA, Wang M, Pazaris M, Willett WC, Eliassen AH, Hunter DJ (2016) Population attributable risk of modifiable and nonmodifiable breast cancer risk factors in postmenopausal breast cancer. Am J Epidemiol 184(12):884–893. https://doi.org/10.1093/aje/kww145

3. Azevedo ESG, de Moura L, Curado MP, Gomes Fda S, Otero U, Rezende LF, Daumas RP, Guimaraes RM, Meira KC, Leite Ida C, Valente JG, Moreira RI, Koifman R, Malta DC, Mello MS, Guedes TW, Boffetta P (2016) The Fraction of cancer attributable to ways of life, infections, occupation, and environmental agents in Brazil in 2020. PLoS ONE 11(2):e0148761. https://doi.org/10.1371/journal.pone.0148761

4. Wilson LF, Page AN, Dunn NA, Pandeya N, Protani MM, Taylor RJ (2013) Population attributable risk of modifiable risk factors associated with invasive breast cancer in women aged 45–69 years in Queensland, Australia. Maturitas 76(4):370–376. https://doi.org/10.1016/j.maturitas.2013.09.002

5. Maas P, Barrdahl M, Joshi AD, Auer PL, Gaudet MM, Milne RL, Schumacher FR, Anderson WF, Check D, Chattopadhyay S, Baglietto L, Berg CD, Chanock SJ, Cox DG, Figueroa JD, Gail MH, Graubard BI, Haiman CA, Hankinson SE, Hoover RN, Isaacs C, Kolonel LN, Le Marchand L, Lee IM, Lindstrom S, Overvad K, Romieu I, Sanchez MJ, Southey MC, Stram DO, Tumino R, VanderWeele TJ, Willett WC, Zhang S, Buring JE, Canzian F, Gapstur SM, Henderson BE, Hunter DJ, Giles GG, Prentice RL, Ziegler RG, Kraft P, Garcia-Closas M, Chatterjee N (2016) breast cancer risk from modifiable and nonmodifiable risk factors among white women in the United States. JAMA Oncol 2(10):1295–1302. https://doi.org/10.1001/jamaoncol.2016.1025

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining the Need for Services for Patients at High Risk of Breast Cancer at a Safety-Net Hospital: An Approach to Narrowing the Disparities Gap;Annals of Surgical Oncology;2024-08-13

2. Factors influencing U.S. women’s interest and preferences for breast cancer risk communication: a cross-sectional study from a large tertiary care breast imaging center;BMC Women's Health;2024-06-21

3. Spectral Flow Cytometry Methods and Pipelines for Comprehensive Immunoprofiling of Human Peripheral Blood and Bone Marrow;Cancer Research Communications;2024-03-25

4. Inequities in referrals to a breast cancer risk assessment and prevention clinic: a mixed methods study;BMC Primary Care;2023-08-25

5. Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen;Breast Cancer Research and Treatment;2022-04-04